Atreca Inc Performance
| BCELDelisted Stock | USD 1.04 0.02 1.89% |
The firm shows a Beta (market volatility) of -0.0792, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Atreca are expected to decrease at a much lower rate. During the bear market, Atreca is likely to outperform the market. Atreca Inc right now shows a risk of 0.0%. Please confirm Atreca Inc semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if Atreca Inc will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Atreca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Atreca is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 22 M |
Atreca |
Atreca Relative Risk vs. Return Landscape
If you would invest 104.00 in Atreca Inc on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Atreca Inc or generate 0.0% return on investment over 90 days. Atreca Inc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Atreca, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Atreca Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atreca's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Atreca Inc, and traders can use it to determine the average amount a Atreca's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BCEL |
Based on monthly moving average Atreca is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atreca by adding Atreca to a well-diversified portfolio.
Atreca Fundamentals Growth
Atreca Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Atreca, and Atreca fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atreca Pink Sheet performance.
| Return On Equity | -1.83 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (17.08 M) | |||
| Shares Outstanding | 38.41 M | |||
| Price To Earning | (3.53) X | |||
| Price To Book | 0.28 X | |||
| EBITDA | (76.42 M) | |||
| Cash And Equivalents | 101.73 M | |||
| Cash Per Share | 2.64 X | |||
| Total Debt | 63.88 M | |||
| Debt To Equity | 0.57 % | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | (65.08 M) | |||
| Earnings Per Share | (2.50) X | |||
| Total Asset | 155.03 M | |||
| Retained Earnings | (456.92 M) | |||
| Current Asset | 60.02 M | |||
| Current Liabilities | 3.56 M | |||
About Atreca Performance
By examining Atreca's fundamental ratios, stakeholders can obtain critical insights into Atreca's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Atreca is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.Things to note about Atreca Inc performance evaluation
Checking the ongoing alerts about Atreca for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Atreca Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atreca Inc is not yet fully synchronised with the market data | |
| Atreca Inc has some characteristics of a very speculative penny stock | |
| Atreca Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (97.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atreca Inc currently holds about 101.73 M in cash with (65.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from investing.com: Revolution Medicines executive sells shares worth 977,508 |
- Analyzing Atreca's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atreca's stock is overvalued or undervalued compared to its peers.
- Examining Atreca's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atreca's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atreca's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atreca's pink sheet. These opinions can provide insight into Atreca's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |